Specificity and cooperativity at β-lactamase position 104 in TEM-1/BLIP and SHV-1/BLIP interactions

Proteins: Structure, Function and Bioinformatics

Volumn 79, Issue 4, 2011, Pages 1267-1276

  Hanes, Melinda S ^a,b   Reynolds, Kimberly A ^a,b,f   Mcnamara, Case ^c   Ghosh, Partho ^c   Bonomo, Robert A ^d,e   Kirsch, Jack F ^a   Handel, Tracy M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

BLIP; Cooperativity; Double mutant cycle; Protein protein interaction; Salt bridge; SHV 1; TEM 1

Indexed keywords

BETA LACTAMASE INHIBITOR; BETA LACTAMASE SHV;

ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; MUTANT; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEIN STRUCTURE;

BACTERIAL PROTEINS; BETA-LACTAMASES; BINDING SITES; CRYSTALLOGRAPHY; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN STABILITY; THERMODYNAMICS;

EID: 79952461374     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.22961     Document Type: Article

References (30)

1. Strynadka N, Jensen S, Johns K, Blanchard H, Page M, Matagne A, Frère J, James M. Structural and kinetic characterization of a β-lactamase inhibitor protein. Nature 1994; 368: 657-660.
2. Reynolds KA, Thomson JM, Corbett KD, Bethel CR, Berger JM, Kirsch JF, Bonomo RA, Handel TM. Structural and computational characterization of the SHV-1 β-lactamase/β-lactamaseinhibitor proteininterface. J Biol Chem 2006; 281: 26745-26753.
3. Reynolds KA, Hanes MS, Thomson JM, Antczak AJ, Berger JM, Bonomo RA, Kirsch JF, Handel TM. Computational redesign of the SHV-1 β-lactamase-β-lactamase inhibitor protein interface. J Mol Biol 2008; 382: 1265-1275.
4. Carter PJ, Winter G, Wilkinson AJ, Fersht AR. The use of double mutants to detect structural changes in the active site of the tyrosyl-tRNA synthetase (Bacillus stearothermophilus). Cell 1984; 38: 835-840.
5. Schreiber G, Fersht AR. Energetics of protein-protein interactions: analysis ofthe barnase-barstar interface by single mutations and double mutant cycles. J Mol Biol 1995; 248: 478-486.
6. Moza B, Buonpane R, Zhu P, Herfst C, Rahman A, McCormick J, Kranz D, Sundberg E. Long-range cooperative binding effects in a T cell receptor variable domain. Proc Natl Acad Sci USA 2006; 103: 9867-9872.
7. Wang J, Palzkill T, Chow D-C. Structural insight into the kinetics and ΔCp of interactions between TEM-1 β-lactamase and β-lactamase inhibitory protein (BLIP). J Biol Chem 2009; 284: 595-609.
8. Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. In: Carter CWJ, Sweet RM, editors. Methods in enzymology, Vol. 276. New York: Academic Press; 1997. pp 307-326.
9. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallogr Sect A 1994; 50: 157-163.
10. Vagin AA, Steiner RA, Lebedev AA, Potterton L, McNicholas S, Long F, Murshudov GN. REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use. Acta Crystallogr Sect D 2004; 60(12 Part 1): 2184-2195.
11. Jones TA, Kjeldgaard MO. The manual, Version 7.0. Uppsala, Sweden: Uppsala Software Factory; 1997.
12. Collaborative-Computational-Project. The CCP4 suite: programs for protein crystallography. Acta Crystallogr Sect D 1994; 50: 750-763.
13. Kleywegt G. Use of non-crystallographic symmetry in protein structure refinement. Acta Crystallogr Sect D 1996; 52: 842-857.
14. DeLano WL. The PyMOL molecular graphics system. Palo Alto, CA, USA: DeLano Scientific; 2002. Available at.
15. Cheng Y-C, Prusoff WH. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 1973; 22: 3099-3108.
16. Zhang Z, Palzkill T. Dissecting the protein-protein interface between β-lactamase inhibitory protein and class A β-lactamases. JBiol Chem 2004; 279: 42860-42866.
17. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA 2001; 98: 10037-10041.
18. Horovitz A, Serrano L, Avron B, Bycroft M, Fersht AR. Strength and co-operativity of contributions of surface salt bridges to protein stability. J Mol Biol 1990; 216: 1031-1044.
19. Albeck S, Unger R, Schreiber G. Evaluation of direct and cooperative contributions towards the strength of buried hydrogen bonds and salt bridges. J Mol Biol 2000; 298: 503-520.
20. Harel M, Cohen M, Schreiber G. On the dynamic nature of the transition state for protein-protein association as determined by double-mutant cycle analysis and simulation. J Mol Biol 2007; 371: 180-196.
21. Luong TN, Kirsch JF. A general method for the quantitative analysis of functional chimeras: applications from site-directed mutagenesis and macromolecular association. Protein Sci 2001; 10: 581-591.
22. Chow MA, McElroy KE, Corbett KD, Berger JM, Kirsch JF. Narrowing substrate specificity in a directly evolved enzyme: The A293D mutant of aspartate aminotransferase. Biochemistry 2004; 43: 12780-12787.
23. Pons J, Rajpal A, Kirsch JF. Energetic analysis of an antigen/antibody interface: alanine scanning mutagenesis and double mutant cycles on the hyhel-10/lysozyme interaction. Protein Sci 1999; 8: 958-968.
24. Chen C-Z, Shapiro R. Superadditive and subadditive effects of "Hot Spot" mutations within the interfaces of placental ribonuclease inhibitor with angiogenin and ribonuclease A. Biochemistry 1999; 38: 9273-9285.
25. Hanes MS, Jude KM, Berger JM, Bonomo RA, Handel TM. Structural and biochemical characterization of the interaction between KPC-2 β-lactamase and β-lactamase inhibitor protein. Biochemistry 2009; 48: 9185-9193.
26. Reichmann D, Cohen M, Abramovich R, Dym O, Lim D, Strynadka NCJ, Schreiber G. Binding hot spots in the TEM1-BLIP interfacein light of its modular architecture. J Mol Biol 2007; 365: 663-679.
27. Reichmann D, Rahat O, Albeck S, Meged R, Dym O, Schreiber G. The modular architecture of protein-protein binding interfaces. Proc Natl Acad Sci USA 2005; 102: 57-62.
28. Bueno M, Camacho CJ. Acidic groups docked to well defined wetted pockets at the core of the binding interface: a tale of scoring and missing protein interactions in CAPRI. Proteins 2007; 69: 786-792.
29. Li X, Liang J. Geometric cooperativity and anticooperativity of three-body interactions in native proteins. Proteins 2005; 60: 46-65.
30. Shapiro R, Ruiz-Gutierrez M, Chen C-Z. Analysis of the interactions of human ribonuclease inhibitor with angiogenin and ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "hot spot". J Mol Biol 2000; 302: 497-519.